サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1276353

世界の感染監視ソリューション市場規模、シェア、産業動向分析レポート：製品・サービス別（ソフトウェア（オンプレミス、Webベースソフトウェア）、サービス）、エンドユーザー別、地域別展望・予測、2023～2029年

Global Infection Surveillance Solutions Market Size, Share & Industry Trends Analysis Report By Product & Services (Software (On-premise and Web-based Software) and Services), By End User, By Regional Outlook and Forecast, 2023 - 2029
出版日: | 発行: KBV Research | ページ情報: 英文 205 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
世界の感染監視ソリューション市場規模、シェア、産業動向分析レポート：製品・サービス別（ソフトウェア（オンプレミス、Webベースソフトウェア）、サービス）、エンドユーザー別、地域別展望・予測、2023～2029年
出版日: 2023年04月28日
発行: KBV Research
ページ情報: 英文 205 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

感染監視ソリューション市場規模は、2029年には13億米ドルに達すると予測され、予測期間中のCAGRは12.9%の市場成長率で上昇すると予想されています。

医療コストの上昇に伴い、感染監視のためのソリューションの需要も増加すると予測されています。また、政府の有利なイニシアチブの結果、市場は拡大しています。さらに、ITシステムの分析処理能力が向上しており、ITシステムの技術開発とともに、医療分野で使用される分析ソリューションや感染監視ソリューションの作成を支援しています。

特殊なデータマイニングツールによるアルゴリズムの使用、電子カルテ、特定の臨床語の検出を助ける臨床支援ベースの情報を使用した完全自動化HAIサーベイランスなどは、これらの方法の一部です。感染監視ソリューションの市場は、手術の増加やHAIを回避するための政府の規則など、いくつかの原因によって大きな拡大を経験しています。

COVID-19の影響分析

COVID-19パンデミックの発生は、感染監視ソリューションの市場にとって有益でした。COVID-19のパンデミックは、世界のヘルスケアシステムに負担をかけ、COVID-19患者が医療関連感染症にかかる確率を高めました。医療施設の過疎化は、COVID陽性患者の急激な増加とウイルス感染速度の急上昇によって引き起こされました。また、感染症対策への意識の高まりから、パンデミック後の時期にも感染監視ソリューションへの需要が高まっています。

市場成長要因

抗菌薬スチュワードシッププログラムの採用拡大

感染管理・疫学（APIC）は、増加するHAIを阻止することを目的としています。世界の健康と開発にとって懸念されるのは、抗菌薬耐性（AMR）です。WHOによると、人類にとって世界の公衆衛生上の危険のトップ10のうちの1つがAMRです。WHOは2015年に世界抗菌薬耐性・使用サーベイランスシステム（GLASS）を導入し、ヒトのAMRと薬剤使用サーベイランスの情報を統合しています。医療施設の要求に応えるため、複数の市場参入企業が抗菌薬スチュワードシップのためのサーベイランスソリューションを打ち出しています。これを踏まえ、感染監視ソリューション市場は市場の成長を支えるものと予測されます。

新興国における大きな成長機会

インド、中国、ブラジル、ロシア、ラテンアメリカ、東南アジアなど、経済が発展している国々では、感染監視ソリューション市場に大きな潜在的可能性があると思われます。これは、インドと中国に半数以上の人口が集中し、世界人口のかなりの部分がこれらの地域に集中しているためです。これらの国では、一人当たりの所得の増加、医療意識の向上、病院やクリニックの増加、患者数の増加などにより、より良いヘルスケアサービスの必要性が高まっています。これらの国々における医療機器の製造は、感染制御技術を取り入れる新しい市場の台頭によって後押しされており、市場拡大の見通しが立っています。

市場抑制要因

小規模な組織では導入コストが高くて手が出せない

相互運用性と展開にかかるコストが高いため、ヘルスケア事業者向けのITソフトウェアソリューションの導入は難しく、費用もかさみます。ヘルスケア関連では、さまざまなネットワークを構築することが難しく、ワイヤレスの可能性はほとんどなく、データ漏洩を防ぐために厳格なセキュリティ対策が必要なため、小規模なヘルスケア企業ではインターネットアクセスの統合がより困難となります。さらに、感染監視ソフトは非常に高価なものです。さらに、販売後に機器を統合するための特注インターフェースの構築には、追加の検証や確認が必要で、医療機関の総所有コストに拍車をかけています。小規模な病院や医療グループでは、こうした追加コストを支払うことができないため、ソリューションを導入することができません。このため、感染監視ソリューション市場の成長は鈍化すると予測されています。

製品・サービスの展望

感染監視ソリューション市場は、製品・サービス別にソフトウェアとサービスに区分されます。2022年の感染監視ソリューション市場では、サービス分野がかなりの収益シェアを占めています。これは、感染監視ソフトウェアが継続的な製品アップデートと技術支援を必要とするためです。クライアント（医療機関）は、ベンダー企業の技術知識ベースへのアクセス、製品サポートチームからの支援、アプリケーション管理スキルの習得を必要としており、製品サポート＆メンテナンスサービスの拡大に拍車をかけています。

ソフトウェアの展望

ソフトウェアでは、感染監視ソリューション市場はオンプレミスソフトウェアとWebベースソフトウェアに分けられます。2022年、感染監視ソリューション市場では、オンプレミスセグメントが最大の収益シェアを示しました。この背景には、医療向けITシステムへの安全なアクセスの必要性と、データ漏洩や外部からの攻撃の危険性を減らす必要性があります。その結果、多くの医療企業は、患者データの安全性を保証するために、オンプレミス型のソフトウェアソリューションを支持しています。また、既存のストレージやサーバーを再利用できるため、特に、あるシステムから別のシステムへアップグレードや移行を行う企業にとっては、さらなる利点があります。

エンドユーザーの展望

エンドユーザー別では、感染監視ソリューション市場は、病院、長期ケア施設、その他に分類されます。2022年、感染監視ソリューション市場では、病院分野が最大の収益シェアを記録しました。病院では、HAIの発生頻度の増加やそれに伴う利害関係者の経済的負担を考慮し、感染対策グッズやサービスを導入しています。また、患者数の多さと手術部位感染症（SSI）の発生率の上昇により、市場は拡大しています。

地域別の展望

地域別に見ると、感染監視ソリューション市場は、北米、欧州、アジア太平洋、LAMEAで分析されています。2022年、北米地域は最も高い収益シェアを獲得し、感染監視ソリューション市場を牽引しました。医療費上昇を抑制するためのヘルスケアITソリューションの普及、医療機関の急速な統合、米国におけるHAIの有病率の上昇といった要因から、北米の市場は大きな変化を遂げています。感染監視ソリューションにおいて北米が大きなシェアを占めているもう一つの重要な点は、同地域に豊富な事業があることです。

市場参入企業がとる主な戦略は、パートナーシップと買収です。カーディナルマトリックスで示された分析によると、感染監視ソリューション市場ではOracle Corporationが先行しています。Becton, Dickinson and Company、Wolters Kluwer N.V.、Baxter International, Inc.などの企業は、感染監視ソリューション市場における主要な革新者の一部です。

この市場調査報告書は、市場の主要な利害関係者の分析をカバーしています。本レポートで紹介されている主要企業は、Becton, Dickinson and Company、Oracle Corporation（Cerner Corporation）、Wolters Kluwer N.V., BioMerieux S.A., Baxter International, Inc. Harris Healthcare（Constellation Software, Inc.）, Securitas AB, OSI Systems, Inc.（Spacelabs Healthcare）, Gojo Industries, Inc.およびMerative L.P.（Francisco Partners）です。

目次

第1章 市場範囲と調査手法

  • 市場の定義
  • 目的
  • 市場範囲
  • セグメンテーション
    • 世界の感染監視ソリューション市場：製品・サービス別
    • 世界の感染監視ソリューション市場：エンドユーザー別
    • 世界の感染監視ソリューション市場：地域別
  • 調査手法

第2章 市場概要

  • イントロダクション
    • 概要
      • 市場構成とシナリオ
  • 市場に影響を与える主な要因
    • 市場促進要因
    • 市場抑制要因

第3章 競合分析- 世界

  • KBVカーディナルマトリックス
  • 最近の業界全体の戦略的展開
    • パートナーシップ、コラボレーション、および契約
    • 製品の発売と製品の拡大
    • 買収と合併
  • 主要成功戦略
    • 主要なリーディングストラテジー

第4章 世界の感染監視ソリューション市場：製品・サービス別

  • 世界のソフトウェア市場：地域別
  • 世界の感染監視ソリューション市場：ソフトウェアタイプ別
    • 世界のオンプレミス市場：地域別
    • 世界のWebベースソフトウェア市場：地域別
  • 世界のサービス市場：地域別

第5章 世界の感染監視ソリューション市場：エンドユーザー別

  • 世界の病院市場：地域別
  • 世界の長期ケア施設市場：地域別
  • 世界のその他の市場：地域別

第6章 世界の感染監視ソリューション市場：地域別

  • 北米
    • 北米の市場：国別
      • 米国
      • カナダ
      • メキシコ
      • その他北米地域
  • 欧州
    • 欧州の市場：国別
      • ドイツ
      • 英国
      • フランス
      • ロシア
      • スペイン
      • イタリア
      • その他欧州地域
  • アジア太平洋
    • アジア太平洋の市場：国別
      • 中国
      • 日本
      • インド
      • 韓国
      • シンガポール
      • マレーシア
      • その他アジア太平洋地域
  • ラテンアメリカ・中東・アフリカ
    • ラテンアメリカ・中東・アフリカの市場：国別
      • ブラジル
      • アルゼンチン
      • アラブ首長国連邦
      • サウジアラビア
      • 南アフリカ
      • ナイジェリア
      • その他ラテンアメリカ・中東・アフリカ地域

第7章 企業プロファイル

  • Becton, Dickinson and Company
  • Oracle Corporation（Cerner Corporation）
  • Wolters Kluwer NV
  • BioMerieux SA
  • Baxter International, Inc
  • Harris Healthcare（Constellation Software, Inc）
  • Securitas AB
  • OSI Systems, Inc（Spacelabs Healthcare）
  • Gojo Industries, Inc
  • Merative LP.（Francisco Partners）
図表

LIST OF TABLES

  • TABLE 1 Global Infection Surveillance Solutions Market, 2019 - 2022, USD Million
  • TABLE 2 Global Infection Surveillance Solutions Market, 2023 - 2029, USD Million
  • TABLE 3 Partnerships, Collaborations and Agreements- Infection Surveillance Solutions Market
  • TABLE 4 Product Launches And Product Expansions- Infection Surveillance Solutions Market
  • TABLE 5 Acquisition and Mergers- Infection Surveillance Solutions Market
  • TABLE 6 Global Infection Surveillance Solutions Market by Product & Services, 2019 - 2022, USD Million
  • TABLE 7 Global Infection Surveillance Solutions Market by Product & Services, 2023 - 2029, USD Million
  • TABLE 8 Global Software Market by Region, 2019 - 2022, USD Million
  • TABLE 9 Global Software Market by Region, 2023 - 2029, USD Million
  • TABLE 10 Global Infection Surveillance Solutions Market by Software Type, 2019 - 2022, USD Million
  • TABLE 11 Global Infection Surveillance Solutions Market by Software Type, 2023 - 2029, USD Million
  • TABLE 12 Global On-premise Market by Region, 2019 - 2022, USD Million
  • TABLE 13 Global On-premise Market by Region, 2023 - 2029, USD Million
  • TABLE 14 Global Web-based Software Market by Region, 2019 - 2022, USD Million
  • TABLE 15 Global Web-based Software Market by Region, 2023 - 2029, USD Million
  • TABLE 16 Global Services Market by Region, 2019 - 2022, USD Million
  • TABLE 17 Global Services Market by Region, 2023 - 2029, USD Million
  • TABLE 18 Global Infection Surveillance Solutions Market by End User, 2019 - 2022, USD Million
  • TABLE 19 Global Infection Surveillance Solutions Market by End User, 2023 - 2029, USD Million
  • TABLE 20 Global Hospitals Market by Region, 2019 - 2022, USD Million
  • TABLE 21 Global Hospitals Market by Region, 2023 - 2029, USD Million
  • TABLE 22 Global Long-term Care Facilities Market by Region, 2019 - 2022, USD Million
  • TABLE 23 Global Long-term Care Facilities Market by Region, 2023 - 2029, USD Million
  • TABLE 24 Global Others Market by Region, 2019 - 2022, USD Million
  • TABLE 25 Global Others Market by Region, 2023 - 2029, USD Million
  • TABLE 26 Global Infection Surveillance Solutions Market by Region, 2019 - 2022, USD Million
  • TABLE 27 Global Infection Surveillance Solutions Market by Region, 2023 - 2029, USD Million
  • TABLE 28 North America Infection Surveillance Solutions Market, 2019 - 2022, USD Million
  • TABLE 29 North America Infection Surveillance Solutions Market, 2023 - 2029, USD Million
  • TABLE 30 North America Infection Surveillance Solutions Market by Product & Services, 2019 - 2022, USD Million
  • TABLE 31 North America Infection Surveillance Solutions Market by Product & Services, 2023 - 2029, USD Million
  • TABLE 32 North America Software Market by Country, 2019 - 2022, USD Million
  • TABLE 33 North America Software Market by Country, 2023 - 2029, USD Million
  • TABLE 34 North America Infection Surveillance Solutions Market by Software Type, 2019 - 2022, USD Million
  • TABLE 35 North America Infection Surveillance Solutions Market by Software Type, 2023 - 2029, USD Million
  • TABLE 36 North America On-premise Market by Country, 2019 - 2022, USD Million
  • TABLE 37 North America On-premise Market by Country, 2023 - 2029, USD Million
  • TABLE 38 North America Web-based Software Market by Country, 2019 - 2022, USD Million
  • TABLE 39 North America Web-based Software Market by Country, 2023 - 2029, USD Million
  • TABLE 40 North America Services Market by Country, 2019 - 2022, USD Million
  • TABLE 41 North America Services Market by Country, 2023 - 2029, USD Million
  • TABLE 42 North America Infection Surveillance Solutions Market by End User, 2019 - 2022, USD Million
  • TABLE 43 North America Infection Surveillance Solutions Market by End User, 2023 - 2029, USD Million
  • TABLE 44 North America Hospitals Market by Country, 2019 - 2022, USD Million
  • TABLE 45 North America Hospitals Market by Country, 2023 - 2029, USD Million
  • TABLE 46 North America Long-term Care Facilities Market by Country, 2019 - 2022, USD Million
  • TABLE 47 North America Long-term Care Facilities Market by Country, 2023 - 2029, USD Million
  • TABLE 48 North America Others Market by Country, 2019 - 2022, USD Million
  • TABLE 49 North America Others Market by Country, 2023 - 2029, USD Million
  • TABLE 50 North America Infection Surveillance Solutions Market by Country, 2019 - 2022, USD Million
  • TABLE 51 North America Infection Surveillance Solutions Market by Country, 2023 - 2029, USD Million
  • TABLE 52 US Infection Surveillance Solutions Market, 2019 - 2022, USD Million
  • TABLE 53 US Infection Surveillance Solutions Market, 2023 - 2029, USD Million
  • TABLE 54 US Infection Surveillance Solutions Market by Product & Services, 2019 - 2022, USD Million
  • TABLE 55 US Infection Surveillance Solutions Market by Product & Services, 2023 - 2029, USD Million
  • TABLE 56 US Infection Surveillance Solutions Market by Software Type, 2019 - 2022, USD Million
  • TABLE 57 US Infection Surveillance Solutions Market by Software Type, 2023 - 2029, USD Million
  • TABLE 58 US Infection Surveillance Solutions Market by End User, 2019 - 2022, USD Million
  • TABLE 59 US Infection Surveillance Solutions Market by End User, 2023 - 2029, USD Million
  • TABLE 60 Canada Infection Surveillance Solutions Market, 2019 - 2022, USD Million
  • TABLE 61 Canada Infection Surveillance Solutions Market, 2023 - 2029, USD Million
  • TABLE 62 Canada Infection Surveillance Solutions Market by Product & Services, 2019 - 2022, USD Million
  • TABLE 63 Canada Infection Surveillance Solutions Market by Product & Services, 2023 - 2029, USD Million
  • TABLE 64 Canada Infection Surveillance Solutions Market by Software Type, 2019 - 2022, USD Million
  • TABLE 65 Canada Infection Surveillance Solutions Market by Software Type, 2023 - 2029, USD Million
  • TABLE 66 Canada Infection Surveillance Solutions Market by End User, 2019 - 2022, USD Million
  • TABLE 67 Canada Infection Surveillance Solutions Market by End User, 2023 - 2029, USD Million
  • TABLE 68 Mexico Infection Surveillance Solutions Market, 2019 - 2022, USD Million
  • TABLE 69 Mexico Infection Surveillance Solutions Market, 2023 - 2029, USD Million
  • TABLE 70 Mexico Infection Surveillance Solutions Market by Product & Services, 2019 - 2022, USD Million
  • TABLE 71 Mexico Infection Surveillance Solutions Market by Product & Services, 2023 - 2029, USD Million
  • TABLE 72 Mexico Infection Surveillance Solutions Market by Software Type, 2019 - 2022, USD Million
  • TABLE 73 Mexico Infection Surveillance Solutions Market by Software Type, 2023 - 2029, USD Million
  • TABLE 74 Mexico Infection Surveillance Solutions Market by End User, 2019 - 2022, USD Million
  • TABLE 75 Mexico Infection Surveillance Solutions Market by End User, 2023 - 2029, USD Million
  • TABLE 76 Rest of North America Infection Surveillance Solutions Market, 2019 - 2022, USD Million
  • TABLE 77 Rest of North America Infection Surveillance Solutions Market, 2023 - 2029, USD Million
  • TABLE 78 Rest of North America Infection Surveillance Solutions Market by Product & Services, 2019 - 2022, USD Million
  • TABLE 79 Rest of North America Infection Surveillance Solutions Market by Product & Services, 2023 - 2029, USD Million
  • TABLE 80 Rest of North America Infection Surveillance Solutions Market by Software Type, 2019 - 2022, USD Million
  • TABLE 81 Rest of North America Infection Surveillance Solutions Market by Software Type, 2023 - 2029, USD Million
  • TABLE 82 Rest of North America Infection Surveillance Solutions Market by End User, 2019 - 2022, USD Million
  • TABLE 83 Rest of North America Infection Surveillance Solutions Market by End User, 2023 - 2029, USD Million
  • TABLE 84 Europe Infection Surveillance Solutions Market, 2019 - 2022, USD Million
  • TABLE 85 Europe Infection Surveillance Solutions Market, 2023 - 2029, USD Million
  • TABLE 86 Europe Infection Surveillance Solutions Market by Product & Services, 2019 - 2022, USD Million
  • TABLE 87 Europe Infection Surveillance Solutions Market by Product & Services, 2023 - 2029, USD Million
  • TABLE 88 Europe Software Market by Country, 2019 - 2022, USD Million
  • TABLE 89 Europe Software Market by Country, 2023 - 2029, USD Million
  • TABLE 90 Europe Infection Surveillance Solutions Market by Software Type, 2019 - 2022, USD Million
  • TABLE 91 Europe Infection Surveillance Solutions Market by Software Type, 2023 - 2029, USD Million
  • TABLE 92 Europe On-premise Market by Country, 2019 - 2022, USD Million
  • TABLE 93 Europe On-premise Market by Country, 2023 - 2029, USD Million
  • TABLE 94 Europe Web-based Software Market by Country, 2019 - 2022, USD Million
  • TABLE 95 Europe Web-based Software Market by Country, 2023 - 2029, USD Million
  • TABLE 96 Europe Services Market by Country, 2019 - 2022, USD Million
  • TABLE 97 Europe Services Market by Country, 2023 - 2029, USD Million
  • TABLE 98 Europe Infection Surveillance Solutions Market by End User, 2019 - 2022, USD Million
  • TABLE 99 Europe Infection Surveillance Solutions Market by End User, 2023 - 2029, USD Million
  • TABLE 100 Europe Hospitals Market by Country, 2019 - 2022, USD Million
  • TABLE 101 Europe Hospitals Market by Country, 2023 - 2029, USD Million
  • TABLE 102 Europe Long-term Care Facilities Market by Country, 2019 - 2022, USD Million
  • TABLE 103 Europe Long-term Care Facilities Market by Country, 2023 - 2029, USD Million
  • TABLE 104 Europe Others Market by Country, 2019 - 2022, USD Million
  • TABLE 105 Europe Others Market by Country, 2023 - 2029, USD Million
  • TABLE 106 Europe Infection Surveillance Solutions Market by Country, 2019 - 2022, USD Million
  • TABLE 107 Europe Infection Surveillance Solutions Market by Country, 2023 - 2029, USD Million
  • TABLE 108 Germany Infection Surveillance Solutions Market, 2019 - 2022, USD Million
  • TABLE 109 Germany Infection Surveillance Solutions Market, 2023 - 2029, USD Million
  • TABLE 110 Germany Infection Surveillance Solutions Market by Product & Services, 2019 - 2022, USD Million
  • TABLE 111 Germany Infection Surveillance Solutions Market by Product & Services, 2023 - 2029, USD Million
  • TABLE 112 Germany Infection Surveillance Solutions Market by Software Type, 2019 - 2022, USD Million
  • TABLE 113 Germany Infection Surveillance Solutions Market by Software Type, 2023 - 2029, USD Million
  • TABLE 114 Germany Infection Surveillance Solutions Market by End User, 2019 - 2022, USD Million
  • TABLE 115 Germany Infection Surveillance Solutions Market by End User, 2023 - 2029, USD Million
  • TABLE 116 UK Infection Surveillance Solutions Market, 2019 - 2022, USD Million
  • TABLE 117 UK Infection Surveillance Solutions Market, 2023 - 2029, USD Million
  • TABLE 118 UK Infection Surveillance Solutions Market by Product & Services, 2019 - 2022, USD Million
  • TABLE 119 UK Infection Surveillance Solutions Market by Product & Services, 2023 - 2029, USD Million
  • TABLE 120 UK Infection Surveillance Solutions Market by Software Type, 2019 - 2022, USD Million
  • TABLE 121 UK Infection Surveillance Solutions Market by Software Type, 2023 - 2029, USD Million
  • TABLE 122 UK Infection Surveillance Solutions Market by End User, 2019 - 2022, USD Million
  • TABLE 123 UK Infection Surveillance Solutions Market by End User, 2023 - 2029, USD Million
  • TABLE 124 France Infection Surveillance Solutions Market, 2019 - 2022, USD Million
  • TABLE 125 France Infection Surveillance Solutions Market, 2023 - 2029, USD Million
  • TABLE 126 France Infection Surveillance Solutions Market by Product & Services, 2019 - 2022, USD Million
  • TABLE 127 France Infection Surveillance Solutions Market by Product & Services, 2023 - 2029, USD Million
  • TABLE 128 France Infection Surveillance Solutions Market by Software Type, 2019 - 2022, USD Million
  • TABLE 129 France Infection Surveillance Solutions Market by Software Type, 2023 - 2029, USD Million
  • TABLE 130 France Infection Surveillance Solutions Market by End User, 2019 - 2022, USD Million
  • TABLE 131 France Infection Surveillance Solutions Market by End User, 2023 - 2029, USD Million
  • TABLE 132 Russia Infection Surveillance Solutions Market, 2019 - 2022, USD Million
  • TABLE 133 Russia Infection Surveillance Solutions Market, 2023 - 2029, USD Million
  • TABLE 134 Russia Infection Surveillance Solutions Market by Product & Services, 2019 - 2022, USD Million
  • TABLE 135 Russia Infection Surveillance Solutions Market by Product & Services, 2023 - 2029, USD Million
  • TABLE 136 Russia Infection Surveillance Solutions Market by Software Type, 2019 - 2022, USD Million
  • TABLE 137 Russia Infection Surveillance Solutions Market by Software Type, 2023 - 2029, USD Million
  • TABLE 138 Russia Infection Surveillance Solutions Market by End User, 2019 - 2022, USD Million
  • TABLE 139 Russia Infection Surveillance Solutions Market by End User, 2023 - 2029, USD Million
  • TABLE 140 Spain Infection Surveillance Solutions Market, 2019 - 2022, USD Million
  • TABLE 141 Spain Infection Surveillance Solutions Market, 2023 - 2029, USD Million
  • TABLE 142 Spain Infection Surveillance Solutions Market by Product & Services, 2019 - 2022, USD Million
  • TABLE 143 Spain Infection Surveillance Solutions Market by Product & Services, 2023 - 2029, USD Million
  • TABLE 144 Spain Infection Surveillance Solutions Market by Software Type, 2019 - 2022, USD Million
  • TABLE 145 Spain Infection Surveillance Solutions Market by Software Type, 2023 - 2029, USD Million
  • TABLE 146 Spain Infection Surveillance Solutions Market by End User, 2019 - 2022, USD Million
  • TABLE 147 Spain Infection Surveillance Solutions Market by End User, 2023 - 2029, USD Million
  • TABLE 148 Italy Infection Surveillance Solutions Market, 2019 - 2022, USD Million
  • TABLE 149 Italy Infection Surveillance Solutions Market, 2023 - 2029, USD Million
  • TABLE 150 Italy Infection Surveillance Solutions Market by Product & Services, 2019 - 2022, USD Million
  • TABLE 151 Italy Infection Surveillance Solutions Market by Product & Services, 2023 - 2029, USD Million
  • TABLE 152 Italy Infection Surveillance Solutions Market by Software Type, 2019 - 2022, USD Million
  • TABLE 153 Italy Infection Surveillance Solutions Market by Software Type, 2023 - 2029, USD Million
  • TABLE 154 Italy Infection Surveillance Solutions Market by End User, 2019 - 2022, USD Million
  • TABLE 155 Italy Infection Surveillance Solutions Market by End User, 2023 - 2029, USD Million
  • TABLE 156 Rest of Europe Infection Surveillance Solutions Market, 2019 - 2022, USD Million
  • TABLE 157 Rest of Europe Infection Surveillance Solutions Market, 2023 - 2029, USD Million
  • TABLE 158 Rest of Europe Infection Surveillance Solutions Market by Product & Services, 2019 - 2022, USD Million
  • TABLE 159 Rest of Europe Infection Surveillance Solutions Market by Product & Services, 2023 - 2029, USD Million
  • TABLE 160 Rest of Europe Infection Surveillance Solutions Market by Software Type, 2019 - 2022, USD Million
  • TABLE 161 Rest of Europe Infection Surveillance Solutions Market by Software Type, 2023 - 2029, USD Million
  • TABLE 162 Rest of Europe Infection Surveillance Solutions Market by End User, 2019 - 2022, USD Million
  • TABLE 163 Rest of Europe Infection Surveillance Solutions Market by End User, 2023 - 2029, USD Million
  • TABLE 164 Asia Pacific Infection Surveillance Solutions Market, 2019 - 2022, USD Million
  • TABLE 165 Asia Pacific Infection Surveillance Solutions Market, 2023 - 2029, USD Million
  • TABLE 166 Asia Pacific Infection Surveillance Solutions Market by Product & Services, 2019 - 2022, USD Million
  • TABLE 167 Asia Pacific Infection Surveillance Solutions Market by Product & Services, 2023 - 2029, USD Million
  • TABLE 168 Asia Pacific Software Market by Country, 2019 - 2022, USD Million
  • TABLE 169 Asia Pacific Software Market by Country, 2023 - 2029, USD Million
  • TABLE 170 Asia Pacific Infection Surveillance Solutions Market by Software Type, 2019 - 2022, USD Million
  • TABLE 171 Asia Pacific Infection Surveillance Solutions Market by Software Type, 2023 - 2029, USD Million
  • TABLE 172 Asia Pacific On-premise Market by Country, 2019 - 2022, USD Million
  • TABLE 173 Asia Pacific On-premise Market by Country, 2023 - 2029, USD Million
  • TABLE 174 Asia Pacific Web-based Software Market by Country, 2019 - 2022, USD Million
  • TABLE 175 Asia Pacific Web-based Software Market by Country, 2023 - 2029, USD Million
  • TABLE 176 Asia Pacific Services Market by Country, 2019 - 2022, USD Million
  • TABLE 177 Asia Pacific Services Market by Country, 2023 - 2029, USD Million
  • TABLE 178 Asia Pacific Infection Surveillance Solutions Market by End User, 2019 - 2022, USD Million
  • TABLE 179 Asia Pacific Infection Surveillance Solutions Market by End User, 2023 - 2029, USD Million
  • TABLE 180 Asia Pacific Hospitals Market by Country, 2019 - 2022, USD Million
  • TABLE 181 Asia Pacific Hospitals Market by Country, 2023 - 2029, USD Million
  • TABLE 182 Asia Pacific Long-term Care Facilities Market by Country, 2019 - 2022, USD Million
  • TABLE 183 Asia Pacific Long-term Care Facilities Market by Country, 2023 - 2029, USD Million
  • TABLE 184 Asia Pacific Others Market by Country, 2019 - 2022, USD Million
  • TABLE 185 Asia Pacific Others Market by Country, 2023 - 2029, USD Million
  • TABLE 186 Asia Pacific Infection Surveillance Solutions Market by Country, 2019 - 2022, USD Million
  • TABLE 187 Asia Pacific Infection Surveillance Solutions Market by Country, 2023 - 2029, USD Million
  • TABLE 188 China Infection Surveillance Solutions Market, 2019 - 2022, USD Million
  • TABLE 189 China Infection Surveillance Solutions Market, 2023 - 2029, USD Million
  • TABLE 190 China Infection Surveillance Solutions Market by Product & Services, 2019 - 2022, USD Million
  • TABLE 191 China Infection Surveillance Solutions Market by Product & Services, 2023 - 2029, USD Million
  • TABLE 192 China Infection Surveillance Solutions Market by Software Type, 2019 - 2022, USD Million
  • TABLE 193 China Infection Surveillance Solutions Market by Software Type, 2023 - 2029, USD Million
  • TABLE 194 China Infection Surveillance Solutions Market by End User, 2019 - 2022, USD Million
  • TABLE 195 China Infection Surveillance Solutions Market by End User, 2023 - 2029, USD Million
  • TABLE 196 Japan Infection Surveillance Solutions Market, 2019 - 2022, USD Million
  • TABLE 197 Japan Infection Surveillance Solutions Market, 2023 - 2029, USD Million
  • TABLE 198 Japan Infection Surveillance Solutions Market by Product & Services, 2019 - 2022, USD Million
  • TABLE 199 Japan Infection Surveillance Solutions Market by Product & Services, 2023 - 2029, USD Million
  • TABLE 200 Japan Infection Surveillance Solutions Market by Software Type, 2019 - 2022, USD Million
  • TABLE 201 Japan Infection Surveillance Solutions Market by Software Type, 2023 - 2029, USD Million
  • TABLE 202 Japan Infection Surveillance Solutions Market by End User, 2019 - 2022, USD Million
  • TABLE 203 Japan Infection Surveillance Solutions Market by End User, 2023 - 2029, USD Million
  • TABLE 204 India Infection Surveillance Solutions Market, 2019 - 2022, USD Million
  • TABLE 205 India Infection Surveillance Solutions Market, 2023 - 2029, USD Million
  • TABLE 206 India Infection Surveillance Solutions Market by Product & Services, 2019 - 2022, USD Million
  • TABLE 207 India Infection Surveillance Solutions Market by Product & Services, 2023 - 2029, USD Million
  • TABLE 208 India Infection Surveillance Solutions Market by Software Type, 2019 - 2022, USD Million
  • TABLE 209 India Infection Surveillance Solutions Market by Software Type, 2023 - 2029, USD Million
  • TABLE 210 India Infection Surveillance Solutions Market by End User, 2019 - 2022, USD Million
  • TABLE 211 India Infection Surveillance Solutions Market by End User, 2023 - 2029, USD Million
  • TABLE 212 South Korea Infection Surveillance Solutions Market, 2019 - 2022, USD Million
  • TABLE 213 South Korea Infection Surveillance Solutions Market, 2023 - 2029, USD Million
  • TABLE 214 South Korea Infection Surveillance Solutions Market by Product & Services, 2019 - 2022, USD Million
  • TABLE 215 South Korea Infection Surveillance Solutions Market by Product & Services, 2023 - 2029, USD Million
  • TABLE 216 South Korea Infection Surveillance Solutions Market by Software Type, 2019 - 2022, USD Million
  • TABLE 217 South Korea Infection Surveillance Solutions Market by Software Type, 2023 - 2029, USD Million
  • TABLE 218 South Korea Infection Surveillance Solutions Market by End User, 2019 - 2022, USD Million
  • TABLE 219 South Korea Infection Surveillance Solutions Market by End User, 2023 - 2029, USD Million
  • TABLE 220 Singapore Infection Surveillance Solutions Market, 2019 - 2022, USD Million
  • TABLE 221 Singapore Infection Surveillance Solutions Market, 2023 - 2029, USD Million
  • TABLE 222 Singapore Infection Surveillance Solutions Market by Product & Services, 2019 - 2022, USD Million
  • TABLE 223 Singapore Infection Surveillance Solutions Market by Product & Services, 2023 - 2029, USD Million
  • TABLE 224 Singapore Infection Surveillance Solutions Market by Software Type, 2019 - 2022, USD Million
  • TABLE 225 Singapore Infection Surveillance Solutions Market by Software Type, 2023 - 2029, USD Million
  • TABLE 226 Singapore Infection Surveillance Solutions Market by End User, 2019 - 2022, USD Million
  • TABLE 227 Singapore Infection Surveillance Solutions Market by End User, 2023 - 2029, USD Million
  • TABLE 228 Malaysia Infection Surveillance Solutions Market, 2019 - 2022, USD Million
  • TABLE 229 Malaysia Infection Surveillance Solutions Market, 2023 - 2029, USD Million
  • TABLE 230 Malaysia Infection Surveillance Solutions Market by Product & Services, 2019 - 2022, USD Million
  • TABLE 231 Malaysia Infection Surveillance Solutions Market by Product & Services, 2023 - 2029, USD Million
  • TABLE 232 Malaysia Infection Surveillance Solutions Market by Software Type, 2019 - 2022, USD Million
  • TABLE 233 Malaysia Infection Surveillance Solutions Market by Software Type, 2023 - 2029, USD Million
  • TABLE 234 Malaysia Infection Surveillance Solutions Market by End User, 2019 - 2022, USD Million
  • TABLE 235 Malaysia Infection Surveillance Solutions Market by End User, 2023 - 2029, USD Million
  • TABLE 236 Rest of Asia Pacific Infection Surveillance Solutions Market, 2019 - 2022, USD Million
  • TABLE 237 Rest of Asia Pacific Infection Surveillance Solutions Market, 2023 - 2029, USD Million
  • TABLE 238 Rest of Asia Pacific Infection Surveillance Solutions Market by Product & Services, 2019 - 2022, USD Million
  • TABLE 239 Rest of Asia Pacific Infection Surveillance Solutions Market by Product & Services, 2023 - 2029, USD Million
  • TABLE 240 Rest of Asia Pacific Infection Surveillance Solutions Market by Software Type, 2019 - 2022, USD Million
  • TABLE 241 Rest of Asia Pacific Infection Surveillance Solutions Market by Software Type, 2023 - 2029, USD Million
  • TABLE 242 Rest of Asia Pacific Infection Surveillance Solutions Market by End User, 2019 - 2022, USD Million
  • TABLE 243 Rest of Asia Pacific Infection Surveillance Solutions Market by End User, 2023 - 2029, USD Million
  • TABLE 244 LAMEA Infection Surveillance Solutions Market, 2019 - 2022, USD Million
  • TABLE 245 LAMEA Infection Surveillance Solutions Market, 2023 - 2029, USD Million
  • TABLE 246 LAMEA Infection Surveillance Solutions Market by Product & Services, 2019 - 2022, USD Million
  • TABLE 247 LAMEA Infection Surveillance Solutions Market by Product & Services, 2023 - 2029, USD Million
  • TABLE 248 LAMEA Software Market by Country, 2019 - 2022, USD Million
  • TABLE 249 LAMEA Software Market by Country, 2023 - 2029, USD Million
  • TABLE 250 LAMEA Infection Surveillance Solutions Market by Software Type, 2019 - 2022, USD Million
  • TABLE 251 LAMEA Infection Surveillance Solutions Market by Software Type, 2023 - 2029, USD Million
  • TABLE 252 LAMEA On-premise Market by Country, 2019 - 2022, USD Million
  • TABLE 253 LAMEA On-premise Market by Country, 2023 - 2029, USD Million
  • TABLE 254 LAMEA Web-based Software Market by Country, 2019 - 2022, USD Million
  • TABLE 255 LAMEA Web-based Software Market by Country, 2023 - 2029, USD Million
  • TABLE 256 LAMEA Services Market by Country, 2019 - 2022, USD Million
  • TABLE 257 LAMEA Services Market by Country, 2023 - 2029, USD Million
  • TABLE 258 LAMEA Infection Surveillance Solutions Market by End User, 2019 - 2022, USD Million
  • TABLE 259 LAMEA Infection Surveillance Solutions Market by End User, 2023 - 2029, USD Million
  • TABLE 260 LAMEA Hospitals Market by Country, 2019 - 2022, USD Million
  • TABLE 261 LAMEA Hospitals Market by Country, 2023 - 2029, USD Million
  • TABLE 262 LAMEA Long-term Care Facilities Market by Country, 2019 - 2022, USD Million
  • TABLE 263 LAMEA Long-term Care Facilities Market by Country, 2023 - 2029, USD Million
  • TABLE 264 LAMEA Others Market by Country, 2019 - 2022, USD Million
  • TABLE 265 LAMEA Others Market by Country, 2023 - 2029, USD Million
  • TABLE 266 LAMEA Infection Surveillance Solutions Market by Country, 2019 - 2022, USD Million
  • TABLE 267 LAMEA Infection Surveillance Solutions Market by Country, 2023 - 2029, USD Million
  • TABLE 268 Brazil Infection Surveillance Solutions Market, 2019 - 2022, USD Million
  • TABLE 269 Brazil Infection Surveillance Solutions Market, 2023 - 2029, USD Million
  • TABLE 270 Brazil Infection Surveillance Solutions Market by Product & Services, 2019 - 2022, USD Million
  • TABLE 271 Brazil Infection Surveillance Solutions Market by Product & Services, 2023 - 2029, USD Million
  • TABLE 272 Brazil Infection Surveillance Solutions Market by Software Type, 2019 - 2022, USD Million
  • TABLE 273 Brazil Infection Surveillance Solutions Market by Software Type, 2023 - 2029, USD Million
  • TABLE 274 Brazil Infection Surveillance Solutions Market by End User, 2019 - 2022, USD Million
  • TABLE 275 Brazil Infection Surveillance Solutions Market by End User, 2023 - 2029, USD Million
  • TABLE 276 Argentina Infection Surveillance Solutions Market, 2019 - 2022, USD Million
  • TABLE 277 Argentina Infection Surveillance Solutions Market, 2023 - 2029, USD Million
  • TABLE 278 Argentina Infection Surveillance Solutions Market by Product & Services, 2019 - 2022, USD Million
  • TABLE 279 Argentina Infection Surveillance Solutions Market by Product & Services, 2023 - 2029, USD Million
  • TABLE 280 Argentina Infection Surveillance Solutions Market by Software Type, 2019 - 2022, USD Million
  • TABLE 281 Argentina Infection Surveillance Solutions Market by Software Type, 2023 - 2029, USD Million
  • TABLE 282 Argentina Infection Surveillance Solutions Market by End User, 2019 - 2022, USD Million
  • TABLE 283 Argentina Infection Surveillance Solutions Market by End User, 2023 - 2029, USD Million
  • TABLE 284 UAE Infection Surveillance Solutions Market, 2019 - 2022, USD Million
  • TABLE 285 UAE Infection Surveillance Solutions Market, 2023 - 2029, USD Million
  • TABLE 286 UAE Infection Surveillance Solutions Market by Product & Services, 2019 - 2022, USD Million
  • TABLE 287 UAE Infection Surveillance Solutions Market by Product & Services, 2023 - 2029, USD Million
  • TABLE 288 UAE Infection Surveillance Solutions Market by Software Type, 2019 - 2022, USD Million
  • TABLE 289 UAE Infection Surveillance Solutions Market by Software Type, 2023 - 2029, USD Million
  • TABLE 290 UAE Infection Surveillance Solutions Market by End User, 2019 - 2022, USD Million
  • TABLE 291 UAE Infection Surveillance Solutions Market by End User, 2023 - 2029, USD Million
  • TABLE 292 Saudi Arabia Infection Surveillance Solutions Market, 2019 - 2022, USD Million
  • TABLE 293 Saudi Arabia Infection Surveillance Solutions Market, 2023 - 2029, USD Million
  • TABLE 294 Saudi Arabia Infection Surveillance Solutions Market by Product & Services, 2019 - 2022, USD Million
  • TABLE 295 Saudi Arabia Infection Surveillance Solutions Market by Product & Services, 2023 - 2029, USD Million
  • TABLE 296 Saudi Arabia Infection Surveillance Solutions Market by Software Type, 2019 - 2022, USD Million
  • TABLE 297 Saudi Arabia Infection Surveillance Solutions Market by Software Type, 2023 - 2029, USD Million
  • TABLE 298 Saudi Arabia Infection Surveillance Solutions Market by End User, 2019 - 2022, USD Million
  • TABLE 299 Saudi Arabia Infection Surveillance Solutions Market by End User, 2023 - 2029, USD Million
  • TABLE 300 South Africa Infection Surveillance Solutions Market, 2019 - 2022, USD Million
  • TABLE 301 South Africa Infection Surveillance Solutions Market, 2023 - 2029, USD Million
  • TABLE 302 South Africa Infection Surveillance Solutions Market by Product & Services, 2019 - 2022, USD Million
  • TABLE 303 South Africa Infection Surveillance Solutions Market by Product & Services, 2023 - 2029, USD Million
  • TABLE 304 South Africa Infection Surveillance Solutions Market by Software Type, 2019 - 2022, USD Million
  • TABLE 305 South Africa Infection Surveillance Solutions Market by Software Type, 2023 - 2029, USD Million
  • TABLE 306 South Africa Infection Surveillance Solutions Market by End User, 2019 - 2022, USD Million
  • TABLE 307 South Africa Infection Surveillance Solutions Market by End User, 2023 - 2029, USD Million
  • TABLE 308 Nigeria Infection Surveillance Solutions Market, 2019 - 2022, USD Million
  • TABLE 309 Nigeria Infection Surveillance Solutions Market, 2023 - 2029, USD Million
  • TABLE 310 Nigeria Infection Surveillance Solutions Market by Product & Services, 2019 - 2022, USD Million
  • TABLE 311 Nigeria Infection Surveillance Solutions Market by Product & Services, 2023 - 2029, USD Million
  • TABLE 312 Nigeria Infection Surveillance Solutions Market by Software Type, 2019 - 2022, USD Million
  • TABLE 313 Nigeria Infection Surveillance Solutions Market by Software Type, 2023 - 2029, USD Million
  • TABLE 314 Nigeria Infection Surveillance Solutions Market by End User, 2019 - 2022, USD Million
  • TABLE 315 Nigeria Infection Surveillance Solutions Market by End User, 2023 - 2029, USD Million
  • TABLE 316 Rest of LAMEA Infection Surveillance Solutions Market, 2019 - 2022, USD Million
  • TABLE 317 Rest of LAMEA Infection Surveillance Solutions Market, 2023 - 2029, USD Million
  • TABLE 318 Rest of LAMEA Infection Surveillance Solutions Market by Product & Services, 2019 - 2022, USD Million
  • TABLE 319 Rest of LAMEA Infection Surveillance Solutions Market by Product & Services, 2023 - 2029, USD Million
  • TABLE 320 Rest of LAMEA Infection Surveillance Solutions Market by Software Type, 2019 - 2022, USD Million
  • TABLE 321 Rest of LAMEA Infection Surveillance Solutions Market by Software Type, 2023 - 2029, USD Million
  • TABLE 322 Rest of LAMEA Infection Surveillance Solutions Market by End User, 2019 - 2022, USD Million
  • TABLE 323 Rest of LAMEA Infection Surveillance Solutions Market by End User, 2023 - 2029, USD Million
  • TABLE 324 Key information - Becton, Dickinson and Company
  • TABLE 325 Key Information - Oracle Corporation
  • TABLE 326 Key information - Wolters Kluwer N.V.
  • TABLE 327 Key information - BioMerieux S.A.
  • TABLE 328 Key Information - Baxter International, Inc.
  • TABLE 329 Key Information - Harris Healthcare
  • TABLE 330 Key Information - Securitas AB
  • TABLE 331 key information - OSI Systems, Inc.
  • TABLE 332 Key information - GOJO Industries, Inc.
  • TABLE 333 Key Information - Merative L.P.

List of Figures

  • FIG 1 Methodology for the research
  • FIG 2 KBV Cardinal Matrix
  • FIG 3 Key Leading Strategies: Percentage Distribution (2019-2023)
  • FIG 4 Global Infection Surveillance Solutions Market share by Product & Services, 2022
  • FIG 5 Global Infection Surveillance Solutions Market share by Product & Services, 2029
  • FIG 6 Global Infection Surveillance Solutions Market by Product & Services, 2019 - 2029, USD Million
  • FIG 7 Global Infection Surveillance Solutions Market share by End User, 2022
  • FIG 8 Global Infection Surveillance Solutions Market share by End User, 2029
  • FIG 9 Global Infection Surveillance Solutions Market by End User, 2019 - 2029, USD Million
  • FIG 10 Global Infection Surveillance Solutions Market share by Region, 2022
  • FIG 11 Global Infection Surveillance Solutions Market share by Region, 2029
  • FIG 12 Global Infection Surveillance Solutions Market by Region, 2019 - 2029, USD Million
  • FIG 13 Recent strategies and developments: Becton, Dickinson and Company
  • FIG 14 Swot analysis: Becton, Dickinson and company
  • FIG 15 SWOT analysis: Oracle Corporation
  • FIG 16 Recent strategies and developments: Wolters Kluwer N.V.
  • FIG 17 Recent strategies and developments: BIOMERIEUX S.A.
  • FIG 18 Recent strategies and developments: Baxter International, Inc.
目次

The Global Infection Surveillance Solutions Market size is expected to reach $1.3 billion by 2029, rising at a market growth of 12.9% CAGR during the forecast period.

The goal of infection surveillance solutions is to accurately apply preventive actions by continuously monitoring and interpreting data related to health. Data from infection surveillance is used to assess and guard against the harm preventable infections can do to patients and healthcare professionals. Hand hygiene, injection safety, antimicrobial resistance, surgical site infections, and hospitals that are open both during and after emergencies are all impacted by infection prevention and control.

During the projected period, key factors driving market growth include increasing antibiotic resistance among bacteria and increasing usage of automation in healthcare settings. In addition, increased hospital stays result from increased surgical procedures performed globally. There will consequently be an increase in the number of patients who contract HAIs.

The demand for solutions for infection surveillance is also anticipated to increase as healthcare costs rise. The market has also been expanding as a result of advantageous government initiatives. Additionally, the ability of IT systems to process analytics has increased, and this, together with technological developments in IT systems, is assisting in the creation of analytical or infection surveillance solutions for use in the healthcare sector.

The use of algorithms with specialized data mining tools, electronic medical records, and completely automated HAI surveillance using clinical support-based information that aids in the detection of specific clinical words are some of these methods. The market for infection surveillance solutions is experiencing significant expansion due to several causes, including increased surgeries and government rules to avoid HAIs.

COVID-19 Impact Analysis

The COVID-19 pandemic outbreak was beneficial for the market for infection control surveillance solutions. The COVID-19 pandemic has put a strain on the global healthcare system and raised the chance of COVID-19 patients contracting a healthcare-associated infection. The overpopulation of healthcare facilities was caused by the exponential growth in COVID-positive patients and the fast-increasing rate of viral transmission. In addition, the increased awareness of infection control resulted in increased demand for infection surveillance solutions even during the post-pandemic period.

Market Growth Factor

Growing adoption of antimicrobial stewardship programs

Infection Control and Epidemiology (APIC) aims to stop the rising number of HAIs. A concern to world health and development is antimicrobial resistance (AMR). According to the WHO, one of the top 10 worldwide public health hazards to humanity is AMR. WHO introduced the Global Antimicrobial Resistance and Use Surveillance System (GLASS) in 2015, integrating information from human AMR and drug use surveillance. To meet the demands of healthcare facilities, several market participants have come up with surveillance solutions for antimicrobial stewardship. In light of this, the infection surveillance solutions market is predicted to support the market growth.

Significant growth opportunities in emerging markets

In nations with rising economies like India, China, Brazil, Russia, and those in Latin America and Southeast Asia, there are likely to be significant potential prospects for the infection surveillance solutions market. This is because a significant amount of the world's population, with more than half living in India and China, is concentrated in these areas. The need for better healthcare services has grown in these nations due to rising per capita income, rising healthcare awareness, an increase in hospitals & clinics, and a large patient population. The manufacturing of medical devices in these nations is being pushed by the rise of new markets to embrace infection control technology, creating prospects for market expansion.

Market Restraining Factor

Cost of deployment is unaffordable for small organizations

The high cost of interoperability and deployment makes it difficult and expensive to implement IT software solutions for healthcare organizations. Smaller healthcare businesses have more difficulty integrating internet access since it is difficult to set up different networks in healthcare contexts, there are few wireless possibilities, and rigorous security measures are required to prevent data breaches. In addition to this, infection surveillance software can be quite pricey. In addition, the construction of a bespoke interface for the integration of a device after sales involves additional validation and verification, which adds to the overall cost of ownership for healthcare providers. Smaller hospitals & healthcare groups are unable to pay these additional costs and hence do deploy the solutions. Due to this, the infection surveillance solutions market is predicted to witness slow growth.

Product & Services Outlook

By product & services, the infection surveillance solutions market is segmented into software and services. The services segment covered a substantial revenue share in the infection surveillance solutions market in 2022. This is because infection surveillance software needs ongoing product updates and technical assistance. Clients' (healthcare providers') need for access to the vendor company's technical knowledge base, assistance from its product support team, and the acquisition of application management skills are fuelling the expansion of the product support & maintenance services.

Software Outlook

Under software, the infection surveillance solutions market is divided into on-premise software and web-based software. In 2022, the on-premise segment witnessed the largest revenue share in the infection surveillance solutions market. This is due to the necessity for safe access to healthcare IT systems as well as the need to reduce the danger of data breaches and outside attacks. As a result, many healthcare businesses favor on-premise software solutions to guarantee the security of their patient data. Reusing existing storage and server gear is an additional advantage, especially for businesses upgrading or migrating from one system to another.

End User Outlook

By end-user, the infection surveillance solutions market is categorized into hospitals, long-term care facilities and others. In 2022, the hospital segment registered the maximum revenue share in the infection surveillance solutions market. Hospitals have adopted infection control goods and services due to the increasing frequency of HAIs and the associated financial burden on stakeholders. The market is also expanding due to the high patient volume and rising incidence of surgical site infections (SSIs).

Regional Outlook

Region wise, the infection surveillance solutions market is analyzed across North America, Europe, Asia Pacific and LAMEA. In 2022, the North America region led the infection surveillance solutions market by generating the highest revenue share. Due to factors like the widespread use of healthcare IT solutions to contain the rise in healthcare costs, rapid consolidation of healthcare providers, and the rising prevalence of HAIs in the US, the market in North America is seeing major changes. Another important aspect of North America's significant market share in infection surveillance solutions is the abundance of businesses in the region.

The major strategies followed by the market participants are Partnerships and Acquisition. Based on the Analysis presented in the Cardinal matrix; Oracle Corporation is the forerunner in the Infection Surveillance Solutions Market. Companies such as Becton, Dickinson and Company, Wolters Kluwer N.V., and Baxter International, Inc. are some of the key innovators in the Infection Surveillance Solutions Market.

The market research report covers the analysis of key stakeholders of the market. Key companies profiled in the report include Becton, Dickinson and Company, Oracle Corporation (Cerner Corporation), Wolters Kluwer N.V., BioMerieux S.A., Baxter International, Inc., Harris Healthcare (Constellation Software, Inc.), Securitas AB, OSI Systems, Inc. (Spacelabs Healthcare), Gojo Industries, Inc. and Merative L.P. (Francisco Partners)

Recent Strategies Deployed in Infection Surveillance Solutions Market

Partnerships, Collaborations and Agreements:

Nov-2022: Wolters partnered with Microsoft, a technology corporation, to enable healthcare organizations to offer better care and service to their customers. Through this acquisition, integrating Microsoft Azure cloud platform with Kluwer's powerful software services for healthcare would allow Wolters' to support virtual care providers and payers to generate and deploy offerings helpful in keeping engaged their patients and members.

Nov-2022: Oracle Cerner came into partnership with Labcorp, a life-science enterprise, for the management of hospital-based laboratories. Through this partnership, Labcorp's diagnostic information capabilities would empower Cerner to advance Cerner's offering facilitating to eliminate manual processes in the labs easing out the information sharing all over the health system, enabling to make quick diagnostic decisions and enhancing patient care.

Sep-2022: BioMerieux announced a partnership with BrightInsight, Inc., a medtech-regulated digital health solutions provider, to offer a Clinical Digital Solution for diagnostics allowing improved clinical decision backing for disease domains all over the diagnostic tests. Utilizing the capabilities of compliant BrightInsight Platform and BrightInsight Disease Management offering, delivering high-level regulated digital health software as a Medical Device categorization, BioMerieux would be able to offer healthcare sector enhanced clinical workflows and contextualize disease awareness and empower clinicians to make actionable informed decisions. Moreover, the partnership would enable BioMerieux to make developments in Clinical Digital solutions for diagnostics.

Jun-2022: BD partnered with Mayo Clinic Platform, a patientcare technological solutions provider, for providing access to patient data from Mayo Clinic Platform. With this partnership, utilizing the power of Mayo Clinic's in delivering advance dataset, and historical data for predictive modeling would enable BD to deliver services that increase clinical trials efficiency and access to patient data utilizing Mayo Clinic Platform. Moreover, Mayo Clinic's data would support BD to advance its product and smoothen medical device regulatory submissions.

Aug-2021: Baxter signed a partnership with Amazon Web Services (AWS), an IT service management enterprise, to enhance enterprise digital transformation. Through this partnership, leveraging the power of the cloud services suite offered by AWS would allow Baxter to propel the growth of Baxter's technology infrastructure enhancing the potential of healthcare data and leading to better patient care.

Product Launches and Product Expansions:

Apr-2023: BioMerieux announced the launch of BIOFIRE FIREWORKS, a powerful software with a user-friendly interface, personalized filters, and smooth integration, for BIOFIRE Systems for making laboratory services and data-based decisions enhanced and quick. BIOFIRE FIREWORKS would be an introduction to the BIOMERIEUX VISION SUITE-a portfolio of Data and IT Solutions for delivering enhanced efficiency and productivity to laboratories across the world. Integrating the potential of all BIOFIRE FILMARRAY systems into one centralized place, the software would provide real-time connectivity to both central and off-site labs. BIOFIRE FILMARRAY systems offer data access from anywhere and at any time improving laboratories workflow to easily manage all its operations delivering better patient care.

Sep-2022: Becton Dickinson announced the launch of BD Research Cloud, a cloud-centered software tool to smoothen flow cytometry workflow helpful in empowering scientists the ability of experimentation with faster time to insights all over immunology, virology, oncology, and infectious disease monitoring. BD Research Cloud would enable users to combine all flow cytometry workflow steps beneficial in creating reagent panels, integrate instruments with data analysis software, store experimental data. The new offering would be a robust and all-inclusive platform connecting instruments, reagents, and data analysis, supporting scientists to potentially discover research for drug development.

May-2022: BD launched automated, infectious disease molecular diagnostics platform. The powerful BD COR™ MX instrument would be a latest analytic instrument option supporting BD COR System. The offering would integrate and automate the entire molecular laboratory workflow starting from sample processing to diagnostic test result for sizeable labs, mitigating the requirement for sorting specimens.

Acquisitions and Mergers:

Jul-2022: BD acquired Parata Systems, a pharmacy automation solutions provider, for offering patient safety solutions. With this acquisition, Parata's expertise in delivering pharmacy automation services would be combined with BD's transformative solutions capabilities to develop suite of advanced pharmacy automation offerings strengthening a growing network of pharmacies to lower costs, improve patient safety and patient experience to serve retail, hospital, and pharmacies.

Apr-2022: BioMerieux S.A. completed the acquisition of Specific Diagnostics, a fast AST solution focused organization, to combat the antimicrobial resistance-a threat with infections from antibiotic resistant pathogens. With this acquisition, integration of Specific Diagnostics' REVEAL Rapid AST system into BioMerieux's suite of microbiology would provide strength to clinicians and laboratories offering enhanced patient outcomes supporting broad distribution network.

Dec-2021: BD took over Scanwell Health, at-home medical testing services provider, for broadening and scaling up the digital at-home medical testing. With this acquisition, leveraging the power of Scanwell Health in offering at-home medical testing facilities would boost BD's capability to deliver its customers at-home diagnostic tests for an extensive range of infectious diseases, including group A strep, Covid-19/influenza A+B, alongside scaling the digital at-home medical testing.

Dec-2021: Baxter International acquired Hillrom, a medical technology provider, to better serve patients, and clinicians. Through this acquisition, combining the Baxter's connectivity technology with Hillrom's Medical Diagnostic Equipment offerings would support Baxter to deliver advanced digital healthcare and better patient care services beneficial in reducing cost and enhancing workflow efficiency.

Scope of the Study

Market Segments covered in the Report:

By Product & Services

  • Software
    • On-premise
    • Web-based Software
  • Services

By End User

  • Hospitals
  • Long-term Care Facilities
  • Others

By Geography

  • North America
    • US
    • Canada
    • Mexico
    • Rest of North America
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Singapore
    • Malaysia
    • Rest of Asia Pacific
  • LAMEA
    • Brazil
    • Argentina
    • UAE
    • Saudi Arabia
    • South Africa
    • Nigeria
    • Rest of LAMEA

Companies Profiled

  • Becton, Dickinson and Company
  • Oracle Corporation (Cerner Corporation)
  • Wolters Kluwer N.V.
  • BioMerieux S.A.
  • Baxter International, Inc.
  • Harris Healthcare (Constellation Software, Inc.)
  • Securitas AB
  • OSI Systems, Inc. (Spacelabs Healthcare)
  • Gojo Industries, Inc.
  • Merative L.P. (Francisco Partners)

Unique Offerings from KBV Research

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology

  • 1.1 Market Definition
  • 1.2 Objectives
  • 1.3 Market Scope
  • 1.4 Segmentation
    • 1.4.1 Global Infection Surveillance Solutions Market, by Product & Services
    • 1.4.2 Global Infection Surveillance Solutions Market, by End User
    • 1.4.3 Global Infection Surveillance Solutions Market, by Geography
  • 1.5 Methodology for the research

Chapter 2. Market Overview

  • 2.1 Introduction
    • 2.1.1 Overview
      • 2.1.1.1 Market Composition & Scenario
  • 2.2 Key Factors Impacting the Market
    • 2.2.1 Market Drivers
    • 2.2.2 Market Restraints

Chapter 3. Competition Analysis - Global

  • 3.1 KBV Cardinal Matrix
  • 3.2 Recent Industry Wide Strategic Developments
    • 3.2.1 Partnerships, Collaborations and Agreements
    • 3.2.2 Product Launches and Product Expansions
    • 3.2.3 Acquisition and Mergers
  • 3.3 Top Winning Strategies
    • 3.3.1 Key Leading Strategies: Percentage Distribution (2019-2023)

Chapter 4. Global Infection Surveillance Solutions Market by Product & Services

  • 4.1 Global Software Market by Region
  • 4.2 Global Infection Surveillance Solutions Market by Software Type
    • 4.2.1 Global On-premise Market by Region
    • 4.2.2 Global Web-based Software Market by Region
  • 4.3 Global Services Market by Region

Chapter 5. Global Infection Surveillance Solutions Market by End User

  • 5.1 Global Hospitals Market by Region
  • 5.2 Global Long-term Care Facilities Market by Region
  • 5.3 Global Others Market by Region

Chapter 6. Global Infection Surveillance Solutions Market by Region

  • 6.1 North America Infection Surveillance Solutions Market
    • 6.1.1 North America Infection Surveillance Solutions Market by Product & Services
      • 6.1.1.1 North America Software Market by Country
      • 6.1.1.2 North America Infection Surveillance Solutions Market by Software Type
        • 6.1.1.2.1 North America On-premise Market by Country
        • 6.1.1.2.2 North America Web-based Software Market by Country
      • 6.1.1.3 North America Services Market by Country
    • 6.1.2 North America Infection Surveillance Solutions Market by End User
      • 6.1.2.1 North America Hospitals Market by Country
      • 6.1.2.2 North America Long-term Care Facilities Market by Country
      • 6.1.2.3 North America Others Market by Country
    • 6.1.3 North America Infection Surveillance Solutions Market by Country
      • 6.1.3.1 US Infection Surveillance Solutions Market
        • 6.1.3.1.1 US Infection Surveillance Solutions Market by Product & Services
        • 6.1.3.1.2 US Infection Surveillance Solutions Market by End User
      • 6.1.3.2 Canada Infection Surveillance Solutions Market
        • 6.1.3.2.1 Canada Infection Surveillance Solutions Market by Product & Services
        • 6.1.3.2.2 Canada Infection Surveillance Solutions Market by End User
      • 6.1.3.3 Mexico Infection Surveillance Solutions Market
        • 6.1.3.3.1 Mexico Infection Surveillance Solutions Market by Product & Services
        • 6.1.3.3.2 Mexico Infection Surveillance Solutions Market by End User
      • 6.1.3.4 Rest of North America Infection Surveillance Solutions Market
        • 6.1.3.4.1 Rest of North America Infection Surveillance Solutions Market by Product & Services
        • 6.1.3.4.2 Rest of North America Infection Surveillance Solutions Market by End User
  • 6.2 Europe Infection Surveillance Solutions Market
    • 6.2.1 Europe Infection Surveillance Solutions Market by Product & Services
      • 6.2.1.1 Europe Software Market by Country
      • 6.2.1.2 Europe Infection Surveillance Solutions Market by Software Type
        • 6.2.1.2.1 Europe On-premise Market by Country
        • 6.2.1.2.2 Europe Web-based Software Market by Country
      • 6.2.1.3 Europe Services Market by Country
    • 6.2.2 Europe Infection Surveillance Solutions Market by End User
      • 6.2.2.1 Europe Hospitals Market by Country
      • 6.2.2.2 Europe Long-term Care Facilities Market by Country
      • 6.2.2.3 Europe Others Market by Country
    • 6.2.3 Europe Infection Surveillance Solutions Market by Country
      • 6.2.3.1 Germany Infection Surveillance Solutions Market
        • 6.2.3.1.1 Germany Infection Surveillance Solutions Market by Product & Services
        • 6.2.3.1.2 Germany Infection Surveillance Solutions Market by End User
      • 6.2.3.2 UK Infection Surveillance Solutions Market
        • 6.2.3.2.1 UK Infection Surveillance Solutions Market by Product & Services
        • 6.2.3.2.2 UK Infection Surveillance Solutions Market by End User
      • 6.2.3.3 France Infection Surveillance Solutions Market
        • 6.2.3.3.1 France Infection Surveillance Solutions Market by Product & Services
        • 6.2.3.3.2 France Infection Surveillance Solutions Market by End User
      • 6.2.3.4 Russia Infection Surveillance Solutions Market
        • 6.2.3.4.1 Russia Infection Surveillance Solutions Market by Product & Services
        • 6.2.3.4.2 Russia Infection Surveillance Solutions Market by End User
      • 6.2.3.5 Spain Infection Surveillance Solutions Market
        • 6.2.3.5.1 Spain Infection Surveillance Solutions Market by Product & Services
        • 6.2.3.5.2 Spain Infection Surveillance Solutions Market by End User
      • 6.2.3.6 Italy Infection Surveillance Solutions Market
        • 6.2.3.6.1 Italy Infection Surveillance Solutions Market by Product & Services
        • 6.2.3.6.2 Italy Infection Surveillance Solutions Market by End User
      • 6.2.3.7 Rest of Europe Infection Surveillance Solutions Market
        • 6.2.3.7.1 Rest of Europe Infection Surveillance Solutions Market by Product & Services
        • 6.2.3.7.2 Rest of Europe Infection Surveillance Solutions Market by End User
  • 6.3 Asia Pacific Infection Surveillance Solutions Market
    • 6.3.1 Asia Pacific Infection Surveillance Solutions Market by Product & Services
      • 6.3.1.1 Asia Pacific Software Market by Country
      • 6.3.1.2 Asia Pacific Infection Surveillance Solutions Market by Software Type
        • 6.3.1.2.1 Asia Pacific On-premise Market by Country
        • 6.3.1.2.2 Asia Pacific Web-based Software Market by Country
      • 6.3.1.3 Asia Pacific Services Market by Country
    • 6.3.2 Asia Pacific Infection Surveillance Solutions Market by End User
      • 6.3.2.1 Asia Pacific Hospitals Market by Country
      • 6.3.2.2 Asia Pacific Long-term Care Facilities Market by Country
      • 6.3.2.3 Asia Pacific Others Market by Country
    • 6.3.3 Asia Pacific Infection Surveillance Solutions Market by Country
      • 6.3.3.1 China Infection Surveillance Solutions Market
        • 6.3.3.1.1 China Infection Surveillance Solutions Market by Product & Services
        • 6.3.3.1.2 China Infection Surveillance Solutions Market by End User
      • 6.3.3.2 Japan Infection Surveillance Solutions Market
        • 6.3.3.2.1 Japan Infection Surveillance Solutions Market by Product & Services
        • 6.3.3.2.2 Japan Infection Surveillance Solutions Market by End User
      • 6.3.3.3 India Infection Surveillance Solutions Market
        • 6.3.3.3.1 India Infection Surveillance Solutions Market by Product & Services
        • 6.3.3.3.2 India Infection Surveillance Solutions Market by End User
      • 6.3.3.4 South Korea Infection Surveillance Solutions Market
        • 6.3.3.4.1 South Korea Infection Surveillance Solutions Market by Product & Services
        • 6.3.3.4.2 South Korea Infection Surveillance Solutions Market by End User
      • 6.3.3.5 Singapore Infection Surveillance Solutions Market
        • 6.3.3.5.1 Singapore Infection Surveillance Solutions Market by Product & Services
        • 6.3.3.5.2 Singapore Infection Surveillance Solutions Market by End User
      • 6.3.3.6 Malaysia Infection Surveillance Solutions Market
        • 6.3.3.6.1 Malaysia Infection Surveillance Solutions Market by Product & Services
        • 6.3.3.6.2 Malaysia Infection Surveillance Solutions Market by End User
      • 6.3.3.7 Rest of Asia Pacific Infection Surveillance Solutions Market
        • 6.3.3.7.1 Rest of Asia Pacific Infection Surveillance Solutions Market by Product & Services
        • 6.3.3.7.2 Rest of Asia Pacific Infection Surveillance Solutions Market by End User
  • 6.4 LAMEA Infection Surveillance Solutions Market
    • 6.4.1 LAMEA Infection Surveillance Solutions Market by Product & Services
      • 6.4.1.1 LAMEA Software Market by Country
      • 6.4.1.2 LAMEA Infection Surveillance Solutions Market by Software Type
        • 6.4.1.2.1 LAMEA On-premise Market by Country
        • 6.4.1.2.2 LAMEA Web-based Software Market by Country
      • 6.4.1.3 LAMEA Services Market by Country
    • 6.4.2 LAMEA Infection Surveillance Solutions Market by End User
      • 6.4.2.1 LAMEA Hospitals Market by Country
      • 6.4.2.2 LAMEA Long-term Care Facilities Market by Country
      • 6.4.2.3 LAMEA Others Market by Country
    • 6.4.3 LAMEA Infection Surveillance Solutions Market by Country
      • 6.4.3.1 Brazil Infection Surveillance Solutions Market
        • 6.4.3.1.1 Brazil Infection Surveillance Solutions Market by Product & Services
        • 6.4.3.1.2 Brazil Infection Surveillance Solutions Market by End User
      • 6.4.3.2 Argentina Infection Surveillance Solutions Market
        • 6.4.3.2.1 Argentina Infection Surveillance Solutions Market by Product & Services
        • 6.4.3.2.2 Argentina Infection Surveillance Solutions Market by End User
      • 6.4.3.3 UAE Infection Surveillance Solutions Market
        • 6.4.3.3.1 UAE Infection Surveillance Solutions Market by Product & Services
        • 6.4.3.3.2 UAE Infection Surveillance Solutions Market by End User
      • 6.4.3.4 Saudi Arabia Infection Surveillance Solutions Market
        • 6.4.3.4.1 Saudi Arabia Infection Surveillance Solutions Market by Product & Services
        • 6.4.3.4.2 Saudi Arabia Infection Surveillance Solutions Market by End User
      • 6.4.3.5 South Africa Infection Surveillance Solutions Market
        • 6.4.3.5.1 South Africa Infection Surveillance Solutions Market by Product & Services
        • 6.4.3.5.2 South Africa Infection Surveillance Solutions Market by End User
      • 6.4.3.6 Nigeria Infection Surveillance Solutions Market
        • 6.4.3.6.1 Nigeria Infection Surveillance Solutions Market by Product & Services
        • 6.4.3.6.2 Nigeria Infection Surveillance Solutions Market by End User
      • 6.4.3.7 Rest of LAMEA Infection Surveillance Solutions Market
        • 6.4.3.7.1 Rest of LAMEA Infection Surveillance Solutions Market by Product & Services
        • 6.4.3.7.2 Rest of LAMEA Infection Surveillance Solutions Market by End User

Chapter 7. Company Profiles

  • 7.1 Becton, Dickinson and Company
    • 7.1.1 Company Overview
    • 7.1.2 Financial Analysis
    • 7.1.3 Segmental and Regional Analysis
    • 7.1.4 Research & Development Expense
    • 7.1.5 Recent strategies and developments:
      • 7.1.5.1 Partnerships, Collaborations, and Agreements:
      • 7.1.5.2 Acquisition and Mergers:
      • 7.1.5.3 Product Launches and Product Expansions:
    • 7.1.6 SWOT Analysis
  • 7.2 Oracle Corporation (Cerner Corporation)
    • 7.2.1 Company Overview
    • 7.2.2 Financial Analysis
    • 7.2.3 Segmental and Regional Analysis
    • 7.2.4 Research & Development Expense
    • 7.2.5 Recent strategies and developments:
      • 7.2.5.1 Partnerships, Collaborations, and Agreements:
    • 7.2.6 SWOT Analysis
  • 7.3 Wolters Kluwer N.V.
    • 7.3.1 Company Overview
    • 7.3.2 Financial Analysis
    • 7.3.3 Segmental and Regional Analysis
    • 7.3.4 Research & Development Expenses
    • 7.3.5 Recent strategies and developments:
      • 7.3.5.1 Partnerships, Collaborations, and Agreements:
      • 7.3.5.2 Product Launches and Product Expansions:
  • 7.4 BioMerieux S.A.
    • 7.4.1 Company Overview
    • 7.4.2 Financial Analysis
    • 7.4.3 Segmental and Regional Analysis
    • 7.4.4 Research & Development Expenses
    • 7.4.5 Recent strategies and developments:
      • 7.4.5.1 Partnerships, Collaborations, and Agreements:
      • 7.4.5.2 Acquisition and Mergers:
      • 7.4.5.3 Product Launches and Product Expansions:
  • 7.5 Baxter International, Inc.
    • 7.5.1 Company Overview
    • 7.5.2 Financial Analysis
    • 7.5.3 Segmental Analysis
    • 7.5.4 Research & Development Expense
    • 7.5.5 Recent strategies and developments:
      • 7.5.5.1 Partnerships, Collaborations, and Agreements:
      • 7.5.5.2 Acquisition and Mergers:
  • 7.6 Harris Healthcare (Constellation Software, Inc.)
    • 7.6.1 Company Overview
    • 7.6.2 Financial Analysis
    • 7.6.3 Regional Analysis
    • 7.6.5 Recent strategies and developments:
      • 7.6.5.1 Acquisition and Mergers:
  • 7.7 Securitas AB
    • 7.7.1 Company Overview
    • 7.7.2 Financial Analysis
    • 7.7.3 Segmental and Regional Analysis
  • 7.8 OSI Systems, Inc. (Spacelabs Healthcare)
    • 7.8.1 Company Overview
    • 7.8.2 Financial Analysis
    • 7.8.3 Segmental and Regional Analysis
    • 7.8.4 Research & Development Expense
  • 7.9 Gojo Industries, Inc.
    • 7.9.1 Company Overview
  • 7.10. Merative L.P. (Francisco Partners)
    • 7.10.1 Company Overview